These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 21664918)
1. Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism. Teff KL; Kim SF Physiol Behav; 2011 Sep; 104(4):590-8. PubMed ID: 21664918 [TBL] [Abstract][Full Text] [Related]
2. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121 [TBL] [Abstract][Full Text] [Related]
3. Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics. Volpato AM; Zugno AI; Quevedo J Braz J Psychiatry; 2013; 35(3):295-304. PubMed ID: 24142093 [TBL] [Abstract][Full Text] [Related]
4. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics. Atmaca M; Kuloglu M; Tezcan E; Ustundag B J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665 [TBL] [Abstract][Full Text] [Related]
5. How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Starrenburg FC; Bogers JP Eur Psychiatry; 2009 Apr; 24(3):164-70. PubMed ID: 19285836 [TBL] [Abstract][Full Text] [Related]
6. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Cooper GD; Harrold JA; Halford JC; Goudie AJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447 [TBL] [Abstract][Full Text] [Related]
7. The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain. He M; Deng C; Huang XF CNS Drugs; 2013 Jun; 27(6):423-34. PubMed ID: 23640535 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity. He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461 [TBL] [Abstract][Full Text] [Related]
9. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain? Deng C; Weston-Green K; Huang XF Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):1-4. PubMed ID: 19922755 [TBL] [Abstract][Full Text] [Related]
10. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069 [TBL] [Abstract][Full Text] [Related]
11. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. Lord CC; Wyler SC; Wan R; Castorena CM; Ahmed N; Mathew D; Lee S; Liu C; Elmquist JK J Clin Invest; 2017 Sep; 127(9):3402-3406. PubMed ID: 28805659 [TBL] [Abstract][Full Text] [Related]
12. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects. Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241 [TBL] [Abstract][Full Text] [Related]
13. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats. Choi S; DiSilvio B; Unangst J; Fernstrom JD Life Sci; 2007 Sep; 81(12):1024-30. PubMed ID: 17822717 [TBL] [Abstract][Full Text] [Related]
14. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain. Weston-Green K; Huang XF; Deng C PLoS One; 2012; 7(3):e33548. PubMed ID: 22438946 [TBL] [Abstract][Full Text] [Related]
15. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study. Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354 [TBL] [Abstract][Full Text] [Related]
16. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications. Lian J; Huang XF; Pai N; Deng C Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia. Johnson DE; Yamazaki H; Ward KM; Schmidt AW; Lebel WS; Treadway JL; Gibbs EM; Zawalich WS; Rollema H Diabetes; 2005 May; 54(5):1552-8. PubMed ID: 15855345 [TBL] [Abstract][Full Text] [Related]
18. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents. Melkersson KI; Hulting AL Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683 [TBL] [Abstract][Full Text] [Related]
19. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat. Smith GC; Vickers MH; Shepherd PR Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852 [TBL] [Abstract][Full Text] [Related]
20. Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs. Wang LJ; Ree SC; Huang YS; Hsiao CC; Chen CK Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():260-6. PubMed ID: 23085073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]